Stephen Krieger, MD
 |
Neurologist at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis
|
…on the rise of MS therapeutics and resources
“I am incredibly encouraged by two positive trends in MS in recent years: the development of a multitude of MS therapies, and the rise of empowered, highly-informed patients. These two trends go hand-in-hand, for as clinicians have more numerous and more complex treatment options to offer to our patients, the need for patient education and awareness has become more crucial than ever.
“As MS has become a highly treatable condition, there are also enormous amounts of high-quality, MS educational materials and resources that are now available. These allow patients to be active, true participants in their MS care in collaboration with their treatment team.
“I think this has been an evolution not just of how MS patients seek and direct their care, but also in the way MS clinicians practice. As medicine becomes more ‘personalized’ and treatment strategies can be tailored to a person’s individual course of MS, we also must prioritize listening closely to our patients and educating them comprehensively. As a clinician-educator, I find this to be one of the most gratifying aspects of working in MS, and I think that with the advent of new therapies, the need for patient education will only continue to grow.”
Dr. Stephen Krieger joined the Corinne Goldsmith Dickinson Center (CGDC) for MS as a fellow in multiple sclerosis. He received a 2006 American Academy of Neurology (AAN) Scholarship and a Sylvia Lawry Fellowship in clinical research. Dr. Krieger has a clinical practice at the CGDC for MS, and participates in several MS clinical trials, including those that study oral therapies and monoclonal antibodies. Dr. Krieger is on many advisory boards in the field of MS, and is the neurology residency program director at Mount Sinai. He is an active member of the AAN, who awarded him an A.B. Baker Teacher Recognition Award in 2010.